The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.
Read More…
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Phone302-773-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$6.64 billion
Profitability
Miscellaneous
Employees7,000
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Chemours (NYSE:CC) Frequently Asked Questions
What is Chemours' stock symbol?
Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."
How often does Chemours pay dividends? What is the dividend yield for Chemours?
Chemours announced a quarterly dividend on Wednesday, July 31st. Stockholders of record on Friday, August 16th will be paid a dividend of $0.25 per share on Monday, September 16th. This represents a $1.00 annualized dividend and a dividend yield of 7.69%. The ex-dividend date of this dividend is Thursday, August 15th. View Chemours' Dividend History.
How will Chemours' stock buyback program work?
Chemours declared that its Board of Directors has approved a share repurchase program on Monday, December 4th 2017, which authorizes the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board of directors believes its shares are undervalued.
How were Chemours' earnings last quarter?
Chemours Co (NYSE:CC) released its quarterly earnings results on Thursday, August, 1st. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.90 by $0.18. The specialty chemicals company had revenue of $1.41 billion for the quarter, compared to analysts' expectations of $1.53 billion. Chemours had a net margin of 10.33% and a return on equity of 71.90%. The business's quarterly revenue was down 22.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.71 EPS. View Chemours' Earnings History.
When is Chemours' next earnings date?
What guidance has Chemours issued on next quarter's earnings?
Chemours updated its FY19 earnings guidance on Thursday, August, 1st. The company provided earnings per share guidance of $2.37-3.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.88.
What price target have analysts set for CC?
11 equities research analysts have issued 12 month price objectives for Chemours' shares. Their forecasts range from $16.00 to $52.00. On average, they anticipate Chemours' stock price to reach $32.10 in the next year. This suggests a possible upside of 146.9% from the stock's current price. View Analyst Price Targets for Chemours.
What is the consensus analysts' recommendation for Chemours?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemours.
Has Chemours been receiving favorable news coverage?
News stories about CC stock have been trending positive on Sunday, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemours earned a news impact score of 2.5 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for Chemours.
Who are some of Chemours' key competitors?
Some companies that are related to Chemours include Johnson Matthey (JMPLY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), KURARAY CO LTD/ADR (KURRY), Ingevity (NGVT), Univar (UNVR), Balchem (BCPC), Olin (OLN), Innospec (IOSP), PQ Group (PQG), GCP Applied Technologies (GCP), Innophos (IPHS), Loop Industries (LOOP) and Hawkins (HWKN).
What other stocks do shareholders of Chemours own?
Who are Chemours' key executives?
Chemours' management team includes the folowing people:
- Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
- Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
- Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
- Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
- Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)
Who are Chemours' major shareholders?
Chemours' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.85%), BlackRock Inc. (9.85%), Vanguard Group Inc. (9.48%), Third Point LLC (2.68%), LSV Asset Management (2.36%) and Bank of New York Mellon Corp (1.70%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.
Which institutional investors are selling Chemours stock?
CC stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., BlackRock Inc., Royal Bank of Canada, Schroder Investment Management Group, Schroder Investment Management Group, Parametric Portfolio Associates LLC and Bank of New York Mellon Corp. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.
Which institutional investors are buying Chemours stock?
CC stock was purchased by a variety of institutional investors in the last quarter, including Third Point LLC, Invesco Ltd., Connor Clark & Lunn Investment Management Ltd., M&T Bank Corp, Morgan Stanley, WINTON GROUP Ltd, Nuveen Asset Management LLC and W.E. Donoghue & Co. LLC. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.
How do I buy shares of Chemours?
Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemours' stock price today?
One share of CC stock can currently be purchased for approximately $13.00.
How big of a company is Chemours?
Chemours has a market capitalization of $2.13 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.
What is Chemours' official website?
How can I contact Chemours?
Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]
MarketBeat Community Rating for Chemours (NYSE CC)
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
